Top Healthcare Market Research Panels in Brazil (2026 Edition)
Compare top healthcare market research panels in Brazil for 2026. Find verified physician, patient, and nursing access for your pharmaceutical research needs.
Quick answer
For large-scale, verified healthcare professional and patient access, Global Vox Populi offers the deepest proprietary coverage. For retail and pharmacy channel analytics, NielsenIQ and IQVIA provide established data. For specialized, account-level pharmaceutical intelligence in Brazil, BioNixus and Fine Research offer highly tailored, primary fieldwork solutions.
Sourcing reliable healthcare market research panels in Brazil requires working through a complex environment of clinical, regulatory, and demographic variables. As pharmaceutical firms and medical device manufacturers adjust their commercial strategies in 2026, the need for high-fidelity data on physician sentiment, patient outcomes, and pharmacy channel dynamics has become more acute.
This assessment examines the capabilities of top-tier providers across Brazil, focusing on their ability to recruit hard-to-reach audiences, maintain stringent data quality, and comply with local standards such as ANVISA requirements. Decision-makers must weigh the benefits of syndicated data platforms against the precision of custom primary research when evaluating healthcare market research panels in Brazil to protect their investment directly informs critical portfolio decisions.
Top Healthcare Market Research Panels in Brazil: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | Science Valley Research Institute | Clinical trial operations and R&D | 82.5 |
| 2 | IQVIA Brazil | Syndicated prescription and market data | 81.5 |
| 3 | Global Vox Populi | Verified physician and patient access | 81.0 |
| 4 | BioNixus | Account-level primary research | 81.0 |
| 5 | Kantar Brazil | Brand tracking and creative testing | 79.0 |
| 6 | Fine Research | LATAM-wide healthcare fieldwork | 76.0 |
| 7 | Psyma Pesquisas de Mercado | Full-service qualitative healthcare insights | 75.0 |
| 8 | NielsenIQ Brazil | OTC and pharmacy channel measurement | 72.0 |
| 9 | Euromonitor International | Syndicated market strategy intelligence | 62.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| Science Valley Research Institute | Clinical trial patients, medical investigators | Regulatory audits, GCP compliance | Not stated on pages reviewed | Not published | Not published | Not published |
| IQVIA Brazil | Physicians, patients, pharmacy partners | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Global Vox Populi | Physicians, nurses, patients, payers, providers | License verification, referral, and rolling re-validation | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Not published | 100,600 healthcare professionals; 69,723 nurses and allied health professionals; 1,054,165 patient profiles (in Brazil; Global Vox Populi panel records, Oct 2026) | Not published |
| BioNixus | Physicians, payers, hospital decision-makers | Identity and quality checks on every wave | Not stated on pages reviewed | Not published | Not published | Not published |
| Kantar Brazil | Consumers, non-customers | Panel validation via Qubed AI | Not stated on pages reviewed | Not published | Not published | Not published |
| Fine Research | Healthcare professionals, consumers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Psyma Pesquisas de Mercado | Physicians, patients | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| NielsenIQ Brazil | Consumers, pharmacy shoppers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Euromonitor International | Corporate strategists, market planners | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| Science Valley Research Institute | ● | – | ● | ● | – | ● |
| IQVIA Brazil | ● | – | – | ● | – | – |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| BioNixus | ● | ● | – | ● | – | – |
| Kantar Brazil | ● | ● | ● | ● | – | ● |
| Fine Research | ● | ● | ● | ● | ● | ● |
| Psyma Pesquisas de Mercado | ● | ● | – | ● | – | – |
| NielsenIQ Brazil | ● | – | ● | ● | – | – |
| Euromonitor International | – | – | – | ● | – | ● |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Rigorous vetting of panel composition and quality controls is the primary determinant of research accuracy in the Brazilian healthcare sector.
| Criterion | Weight | What it means here |
|---|---|---|
| Sample Quality and Verification | 25 | This criterion measures how providers recruit and validate their healthcare panels. In Brazil, good quality involves verified medical licenses for professionals and authentic patient profiles. Providers must demonstrate how they check identities, prevent duplicate registrations, and make sure that every respondent is genuinely qualified to provide medical or patient insights. |
| Compliance, Certifications and Security | 20 | This assesses adherence to ISO standards, data privacy laws like LGPD, and healthcare-specific regulations. For Brazil, it requires evidence of secure data handling, clear informed consent, and established protocols for adverse event reporting. High-scoring providers maintain transparent documentation of their ethical frameworks and data protection practices. |
| Target Audience Reach | 15 | This evaluates the depth and breadth of access to specific medical specialties, nursing roles, and patient segments. It looks at the ability to reach low-incidence conditions or specific provider types. Providers should offer granular profiling to make sure researchers can target precise, relevant samples rather than relying on broad, generic lists. |
| Data Quality and Fraud Prevention | 10 | This focuses on technical defenses against bots, fraudulent completes, and poor-quality inputs. Effective providers use device fingerprinting, geo-checks, and trap questions to maintain integrity. In the Brazilian market, they must also detect patterns of straight-lining or speeders to make sure the final dataset reflects thoughtful responses from real human participants. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This examines the range of research formats available, from online surveys and CATI to qualitative methods like focus groups and ethnography. A strong provider offers flexible tools that adapt to the study objective, whether testing a new drug launch or understanding the patient experience through multi-channel data collection. |
| Client Service and Speed | 5 | This measures the responsiveness of project management teams and the time taken to provide proposals or resolve fieldwork issues. High performance is defined by proactive communication and the ability to manage complex studies efficiently, making sure that timelines are met without compromising the rigor of the research process. |
| Pricing and Feasibility Transparency | 5 | This looks at the provider's willingness to share honest feasibility assessments, incidence rates, and clear pricing models. Good providers prioritize long-term partnership over quick sales by reporting what is truly achievable in the Brazilian market, preventing misaligned expectations regarding sample availability or project timelines. |
Why these weights. In healthcare, a respondent who is not a verified professional or a genuine patient invalidates the study, so verification leads (25). Compliance follows at 20 because health data, HIPAA and adverse event reporting carry legal risk. Reach into specialties and conditions (15), fraud prevention and methods (10 each), service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: healthcare market research panels in Brazil
Science Valley Research Institute: best for clinical trial operations and R&D

Strongest fitSuited for pharmaceutical firms requiring operational support for clinical trials and regulatory approval processes.
Science Valley Research Institute provides technical-scientific services in clinical trial operations (CTO) and R&D.
The company maintains a network of clinical research centers, enabling them to execute all phases of clinical trials. Their approach integrates study design, patient recruitment, and data management with a strong emphasis on regulatory compliance and scientific publication.
Scorecard: 82.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | svriglobal.com (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | svriglobal.com (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | svriglobal.com (1 page reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | svriglobal.com (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | svriglobal.com (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | svriglobal.com (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | svriglobal.com (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 82.5 |
Core services
- Clinical Trial Operations: Planning, management, and execution of clinical trials across all phases.
- Regulatory Support: Technical support for protocol approval, drug registration, and patent processes.
- Patient Recruitment: Management and preventive tracking of patient samples for clinical research purposes.
- Scientific Intelligence: Publication of clinical studies and research articles in recognized scientific journals.
Strengths
- Multicenter Infrastructure: Operates 30 clinical research centers in 11 Brazilian states, protecting broad geographical reach.
- Regulatory Rigor: Operations aligned with ANVISA and international clinical research standards.
Innovation and technology
- Tech Science Platform: Integrates clinical trial management with R&D processes to accelerate development timelines.
Impact on businesses
- Accelerated R&D: Supports pharmaceutical firms in bringing innovative treatments and devices to market efficiently.
Why it may fit your brief
Their expertise is deeply clinical. For non-clinical market research, such as brand tracking or consumer sentiment, a dedicated market research panel provider is more appropriate.
IQVIA Brazil: best for syndicated prescription and market data

Strongest fitIdeal for large-scale pharmaceutical firms seeking syndicated data, market forecasting, and clinical trial support.
IQVIA provides comprehensive healthcare data, advanced analytics, and clinical research services in Brazil. Its presence is defined by massive proprietary data assets, including non-identified patient records and prescription audits, which support pharmaceutical companies in working through local market dynamics.
The company integrates technology with human science to offer end-to-end solutions, from clinical development to commercial execution. Their approach is heavily focused on using data-driven intelligence to maximize asset success and improve patient outcomes through evidence generation.
Scorecard: 81.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 81.5 |
Core services
- Real-World Evidence: Generation of data-backed insights to support regulatory approvals and market access strategies.
- Market Intelligence: Tracking of pharmaceutical sales and prescription performance across healthcare channels.
- Clinical Development: Full-service management of clinical trials, including site identification and patient recruitment support.
- Commercial Solutions: Advanced analytics and AI-enabled platforms to optimize field force performance and marketing programs.
Strengths
- Proprietary Data Depth: Access to petabytes of data, including non-identified patient records, providing unique market visibility.
- End-to-End Analytics: Unified platform approach connecting data, technology, and analytics for comprehensive asset management.
Innovation and technology
- IQVIA.ai Platform: Uses agentic AI to predict clinical outcomes and optimize commercial execution.
Impact on businesses
- Risk Mitigation: Helps organizations reduce clinical trial risks and accelerate the time to market for new therapies.
Why it may fit your brief
Their infrastructure is built for high-volume data needs. For highly specific primary research projects requiring rapid turnaround on niche samples, a smaller, more agile agency may be preferable.
Global Vox Populi: best for verified physician and patient access
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant

Strongest fitBest suited for research briefs requiring highly specific clinical audiences or verified patient segments for primary data collection.
Global Vox Populi provides independent primary market research services supported by proprietary panels in over 190 markets, with a dedicated operational footprint in Brazil. The company focuses on direct recruitment of healthcare professionals and patients, prioritizing data integrity through rigorous validation and de-duplication processes.
Their model avoids open-market sample exchanges, relying instead on verified registries and professional communities. This approach allows for granular targeting of specific medical specialties and patient therapeutic areas, supported by a comprehensive suite of qualitative and quantitative methodologies tailored for the Brazilian healthcare environment.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Brazil
100,600 panellists
- Primary & General42,230
- Internal Medicine Subspecialties8,438
- Acute, Peri-operative & Critical Care7,606
- Diagnostic & Laboratory6,968
- Women's & Reproductive Health6,848
- Surgical Specialties5,490
Nurses and allied health panel, in Brazil
69,723 panellists
- Registered Nurses24,111
- Advanced Practice Nurses1,528
- Licensed / Practical / Enrolled Nurses4,443
- Nursing Support (Aides / HCAs)2,600
- Midwives2,156
- Pharmacists & Pharmacy Techs5,140
Patient panel, in Brazil
1,054,165 patient profiles
- Aesthetics & Cosmetic346,987
- Cardiovascular73,778
- Endocrinology & Metabolic57,482
- Women's Health54,285
- Dermatology53,410
- Ophthalmology52,347
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Brazil
1,645 panellists
- Provider: Access & Administrative Roles1,053
- Payer: Access & Coverage Roles592
Scorecard: 81.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 81.0 |
Core services
- Healthcare Professional Research: Access to healthcare professionals including physicians across 70+ specialties and sub-specialties for quantitative and qualitative studies.
- Patient and Caregiver Studies: Comprehensive patient research covering major therapeutic areas, including aesthetics, cardiovascular, and dermatology, with verified profiles for deep insights.
- Nursing and Allied Health: Proprietary nursing and allied health panels, including registered nurses, pharmacists, and technicians, for clinical perspective studies.
- Payer and Provider Insights: Strategic research with payers and providers to understand access, coverage, and administrative dynamics within the Brazilian healthcare system.
Strengths
- Verified Panel Quality: Proprietary panels are recruited via invitation and referral, with healthcare professional licenses and credentials validated on a rolling basis.
- Granular Panel Data: Members are profiled on 45 to 140 data points, allowing for precise targeting of low-incidence populations and specific sub-specialties.
- Rigorous Data Integrity: Multi-layered quality controls include device fingerprinting, geo-checks, and trap questions to remove bots and fraudulent completes before delivery.
Innovation and technology
- Advanced Anti-Fraud Tech: Proprietary platform uses identity and device fingerprinting to maintain high respondent quality and data purity.
- Mobile-First Methodology: Supports WhatsApp-assisted surveys and mobile-optimized interfaces to increase engagement among busy healthcare professionals.
Impact on businesses
- Strategic Launch Support: Provides the primary data foundation for commercial and medical affairs teams to make decisions on product positioning and market access.
- Clinical Evidence Generation: Delivers insights that help pharmaceutical firms understand unmet medical needs and improve patient adherence programs.
Why it may fit your brief
The firm aligns with briefs needing high-quality, verified data and complex study designs. For projects prioritizing syndicated market-level data rather than primary insights, a different provider might be more appropriate.
BioNixus: best for account-level primary research

Strongest fitIdeal for marketing and commercial teams needing granular, account-level intelligence for specific drug or device launches.
BioNixus delivers primary market research with a focus on pharmaceutical and healthcare decision-making. They provide account-level and SKU-level brand versus competitor data, filling the gaps often left by syndicated data feeds through targeted fieldwork in 48 countries, including Brazil.
The company bridges the gap between high-level syndicated data and the specific, on-the-ground realities of hospital and pharmacy channels. Their approach is designed to provide actionable intelligence for commercial, medical affairs, and market access teams.
Scorecard: 81.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 9/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 81.0 |
Core services
- Account-Level Research: Primary data collection at the level of specific hospitals, departments, and retailers.
- Physician Surveys: Statistically solid quantitative and qualitative research with physicians and payers.
- Market Access Support: HTA dossiers, KOL mapping, and pricing/reimbursement studies.
Strengths
- High-Granularity Data: Provides breakdowns at the sub-account and SKU level, not just national averages.
- Actionable Decision Packs: Outputs are designed for direct use by marketing and commercial directors.
Innovation and technology
- Decision-Focused Scoping: Rapid 48-hour proposal turnaround based on specific commercial questions rather than template decks.
Impact on businesses
- Launch Optimization: Informs launch readiness and share plans with precise, actionable evidence.
Why it may fit your brief
Their model is highly tactical. For broad-spectrum consumer tracking or general industry trends, a syndicated data provider may be more cost-effective.
Kantar Brazil: best for brand tracking and creative testing

Strongest fitSuitable for marketing teams focused on brand health, advertising impact, and large-scale consumer segmentation.
Kantar uses a vast network of consumer panels to provide marketing intelligence and brand growth strategies. In Brazil, their health practice focuses on OTC brand tracking, patient journey mapping, and advertising effectiveness, using deep consumer insights to drive commercial performance.
The company emphasizes high-quality data collection through proprietary panels and AI-enabled anti-fraud technology. Their approach balances global scale with local market relevance, offering a range of survey solutions that cater to both DIY and custom research needs.
Scorecard: 79.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.0 |
Core services
- Brand Research: Tracking of brand equity and performance metrics to guide long-term growth strategies.
- Creative Testing: Evaluation of advertising effectiveness to protect ROI across media channels and formats.
- Consumer Journey Studies: Analysis of the path-to-purchase to understand how consumers interact with health and consumer goods brands.
Strengths
- Anti-Fraud Technology: Qubed AI technology detects fraudulent survey activity in milliseconds to protect data integrity.
- Global Panel Scale: Access to millions of panelists globally with solid blending capabilities for hard-to-reach quotas.
Innovation and technology
- Qubed AI: Next-generation anti-fraud technology using neural networks to identify non-human survey responses.
Impact on businesses
- Increased Ad ROI: Helps brands develop creative content that captures attention and drives profitable market outcomes.
Why it may fit your brief
Their panel scale is significant for consumer-facing studies. For highly specialized clinical trials or medical device research, the focus on general consumer behavior may require supplementation by clinical-specialist firms.
Fine Research: best for LATAM-wide healthcare fieldwork

Strongest fitIdeal for international research agencies needing a reliable, regional fieldwork partner in Brazil and wider Latin America.
Fine Research is a dedicated fieldwork specialist with local operations across Latin America. They focus on executing quantitative and qualitative research for healthcare, consumer, and B2B sectors, serving global market research agencies and consulting firms.
The company maintains a significant HCP panel in the region and emphasizes quality through regional operational scale and local expertise. Their project teams are trained in healthcare-specific methodologies and pharmacovigilance standards, protecting consistent execution across diverse markets.
Scorecard: 76.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 76.0 |
Core services
- Healthcare Fieldwork: Quantitative and qualitative data collection, including online surveys, IDIs, and focus groups.
- Regional Coordination: Standardized research execution across multiple Latin American markets with local cultural adaptation.
- Project Management: End-to-end support from proposal development to final delivery.
Strengths
- Regional Scale: Deep operational footprint across Latin America with local teams and proprietary panels.
- Healthcare Training: Teams are trained in pharmacovigilance requirements and international project management standards.
Innovation and technology
- Integrated Fieldwork Tools: Uses the latest technology for video streaming and live observation in qualitative research.
Impact on businesses
- Consistent Regional Data: Helps global partners execute research consistently across diverse operational realities in Latin America.
Why it may fit your brief
They are a field-focused partner that excels at execution. For clients requiring internal strategic consulting or advanced data modeling, they would typically work alongside a full-service agency.
Psyma Pesquisas de Mercado: best for full-service qualitative healthcare insights

Strongest fitBest for clients seeking a high-touch, consultative agency that provides strategic guidance alongside primary data.
Psyma offers a full-service approach to market research, combining methodology with industry expertise. Their health division, Psyma+Exevia Health, serves the pharmaceutical and medical technology sectors throughout the entire product lifecycle, from study design to insights consulting.
The agency emphasizes a personal, consultative relationship, with dedicated teams tailored to each project. Their focus is on understanding the motives behind human behavior, providing strategic recommendations that go beyond raw data collection.
Scorecard: 75.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 3/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 75.0 |
Core services
- Full-Service Research: End-to-end management from study design and fieldwork to analysis and strategic consulting.
- Product Lifecycle Research: Support for all stages, from market potential assessment to post-launch tracking.
- Qualitative Insights: Deep exploration of human motives and patient experiences through focus groups and interviews.
Strengths
- Consultative Approach: Business-issue-first mindset that translates research findings into actionable strategic recommendations.
- Tailored Project Teams: Experts are selected to form a specialized team for each unique client requirement.
Innovation and technology
- AI Insights Accelerator: Uses advanced tools to speed up the translation of research data into strategic insights.
Impact on businesses
- Strategic Decision Making: Provides the foundation for successful marketing strategies and product positioning.
Why it may fit your brief
Their strength is in the 'why' behind the data. For projects that strictly need large-scale, automated data collection, a more tech-heavy or syndicated provider might fit better.
NielsenIQ Brazil: best for OTC and pharmacy channel measurement

Strongest fitBest for consumer health companies needing high-volume retail and pharmacy channel metrics to guide distribution strategies.
NielsenIQ specializes in measuring every consumer transaction to provide actionable insights for retail and consumer health sectors. In Brazil, they are a primary source for pharmacy channel analytics and OTC sell-out measurement, assisting companies in understanding purchasing behaviors and market trends.
Their methodology centers on comprehensive data sets that cover both physical and online retail environments. This allows them to provide a holistic view of the consumer health environment, connecting retail performance to wider market trends and policy outcomes.
Scorecard: 72.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | nielseniq.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | nielseniq.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | nielseniq.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | nielseniq.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | nielseniq.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 6/10 | nielseniq.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | nielseniq.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 72.0 |
Core services
- Retail Measurement: Comprehensive tracking of sales data across pharmacy and retail channels to quantify market share.
- Consumer Intelligence: Analysis of consumer behavior and purchasing journeys through representative consumer panels.
- Market Analytics: Advanced tools for forecasting sales growth and identifying new market trends in CPG and health categories.
Strengths
- Comprehensive Data Coverage: Full view measurement across store, e-commerce, and omnichannel environments.
- Policy Research Support: Ability to map the impact of public health policies and economic changes on consumer spending.
Innovation and technology
- Connect Express Go: User-friendly platform for visualizing and analyzing retail data without requiring large analyst teams.
Impact on businesses
- Strategic Growth Planning: Enables businesses to optimize pricing strategies and identify new opportunities for market entry.
Why it may fit your brief
Their data scales across entire categories. For clinical or professional research involving physician surveys or qualitative depth, this provider is less suited compared to specialized healthcare agencies.
Euromonitor International: best for syndicated market strategy intelligence
Strongest fitIdeal for corporate strategy teams needing high-level syndicated data for market entry or long-term industry planning.
Euromonitor International provides business intelligence through a network of in-country analysts. In Brazil, they offer syndicated market research focused on categories such as vitamins, dietary supplements, and OTC remedies to support corporate strategy and competitive threat assessment.
Their research is designed for strategic planning, providing long-term market trends and competitive environment insights. This enables firms to monitor industry developments and adjust their commercial strategies based on high-level market data.
Scorecard: 62.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 6/10 | Search results and industry sources, Oct 2026 |
| Compliance, Certifications and Security | 20 | 6/10 | Search results and industry sources, Oct 2026 |
| Target Audience Reach | 15 | 6/10 | Search results and industry sources, Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 6/10 | Search results and industry sources, Oct 2026 |
| Market Presence | 10 | 9/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 6/10 | Search results and industry sources, Oct 2026 |
| Client Service and Speed | 5 | 5/10 | Search results and industry sources, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 5/10 | Search results and industry sources, Oct 2026 |
| Weighted score | 100 | 62.0 |
Core services
- Syndicated Research: Detailed reports covering market sizing, competitive dynamics, and future trends in consumer health.
- Strategic Analysis: Consulting support for corporate strategy development and assessment of competitive threats.
Strengths
- Global Analyst Network: Maintains a presence with local analysts who monitor developments in the Brazilian consumer health sector.
Innovation and technology
- Strategic Intelligence Platform: Provides digital access to comprehensive industry reports and data visualization tools.
Impact on businesses
- Market Entry Planning: Informs investment decisions by providing evidence on market growth and saturation levels.
Why it may fit your brief
Their reports are excellent for macro-level strategy. They are not designed for primary field research, patient recruitment, or clinical intelligence, which require specialized clinical panels.
How HCP and patient verification actually works in Brazil
Professional credentials and respondent identities must be validated through direct license checks and multi-stage verification protocols.
Professional License Validation
For healthcare professionals in Brazil, providers must perform a primary source verification of medical or nursing licenses against official registries. This makes sure that the respondent is currently authorized to practice. Buyers should request a sample of the verification process and proof that licenses are checked not just at sign-up but periodically to account for status changes.
Identity and Device Fingerprinting
Every respondent should undergo device fingerprinting to prevent multiple accounts from the same user. This involves checking IP addresses, browser configurations, and hardware IDs. When vetting a provider, ask how they handle suspected duplicates and what technical tools they use to make sure that the individual completing the survey matches the profile registered in their system.
Geographic and VPN Detection
With the rise of international survey fraud, detecting the true geographic location of a respondent is critical. Providers must use advanced geo-tagging and VPN detection to confirm that the respondent is physically located in Brazil. If a provider cannot demonstrate how they filter out VPNs or proxy servers, the risk of non-local, fraudulent data is significantly increased.
Behavioral and Trap Questioning
Data quality is further verified through behavioral markers such as time spent on questions, consistency checks, and trap questions. If a respondent answers too quickly or provides contradictory information, they should be flagged. Ask for the provider's specific criteria for removing respondents and how they handle straight-lining, which is a common indicator of low-quality, automated survey responses.
How to choose the right provider in Brazil
A systematic scorecard approach makes sure that research providers are evaluated based on their operational capacity rather than marketing claims.
- Define Research Objectives: Clarify if you need high-level market data or granular primary insights. This determines whether you choose a syndicated data provider or a primary fieldwork specialist.
- Validate Panel Provenance: Ask if the provider owns their panels or rents them from exchanges. Proprietary panels generally offer higher control over data quality and respondent identity.
- Assess Regulatory Compliance: Verify the provider's ability to handle health data according to LGPD and their protocols for reporting adverse events. Compliance is not optional in the Brazilian healthcare sector.
- Check Feasibility Early: Request a feasibility check before signing a contract to make sure your target audience size is realistic. Avoid providers who promise impossible sample sizes.
- Review Quality Controls: Demand a clear explanation of their anti-fraud technology. Understand exactly how they filter out bots and speeders to make sure the final dataset is usable.
Questions to ask before you commission
- Can you provide a breakdown of how you verify the medical licenses of your healthcare professional panelists in Brazil?
- What specific anti-fraud technology do you use to detect and remove bots, duplicates, and speeders from your panels?
- How does your recruitment process make sure that you reach hard-to-reach or low-incidence patient populations?
- What is your formal protocol for reporting adverse events detected during fieldwork to my organization?
- Can you share your feasibility assessment process and how you handle projects where sample targets are not met?
- Are your data collection operations in Brazil compliant with local LGPD regulations and international standards like ISO 20252?
Common pitfalls to avoid
- Relying on Open Exchanges: Buying sample from open exchanges in Brazil often leads to low data quality and identity fraud, as these sources lack stringent credential verification.
- Ignoring Local Expertise: Failing to partner with teams that understand the Brazilian healthcare system can result in poorly phrased instruments that do not resonate with local clinicians.
- Overestimating Panel Depth: Assuming a general consumer panel can provide clinical insights often leads to misaligned research objectives and unusable data for pharmaceutical decision-making.
- Underestimating Regulatory Risk: Neglecting ANVISA-aligned methodologies and proper consent documentation can lead to legal and ethical issues, potentially invalidating the entire research program.
What a feasibility check should include
A credible feasibility assessment must account for professional availability, incidence rates, and local operational constraints.
Audience Incidence Rates
A proper check must estimate the incidence of your specific audience, especially for rare diseases or niche medical specialties. This prevents over-promising and protects realistic timelines.
Professional Availability
Consider the current workload of Brazilian healthcare professionals when planning fieldwork. A good feasibility check factors in typical hospital shifts and conference schedules.
Geographic Distribution
If the study requires representative coverage across Brazil, feasibility must account for the logistical challenges of reaching professionals outside major urban centers.
Methodological Burden
Assess whether the length and complexity of the survey will discourage participation. High-burden studies require more solid recruitment efforts and incentives.
Conclusion
Selecting the right research partner for Brazil requires balancing the need for deep, primary insights with the requirement for solid data quality. For projects involving clinical trials or sensitive medical data, specialized agencies with proven multicenter networks and regulatory expertise provide the safest and most effective foundation. Conversely, for broader market tracking and brand health studies, providers with large-scale consumer panels and AI-enabled quality controls offer the necessary depth and speed.
We recommend using the scorecard provided on this page to evaluate providers based on your specific research objectives. Prioritize those that offer transparent feasibility reporting and can demonstrate clear, verifiable processes for audience recruitment. By focusing on these core criteria, your organization can make sure that its research spend leads to actionable, evidence-based decisions in the competitive Brazilian healthcare market.
Planning research in Brazil? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
How do I find healthcare market research panels in Brazil?
You should look for research providers that demonstrate a proprietary, verified panel in Brazil. Start by identifying agencies that specialize in healthcare and are willing to share their recruitment methodology and validation processes. Avoid open-market sample exchanges, as they often lack the clinical rigor required for pharmaceutical or medical device research.
Which market research companies in Brazil specialize in pharmaceutical research?
Several firms, such as Global Vox Populi, BioNixus, and Science Valley Research Institute, have dedicated practices for pharmaceutical research. These companies focus on physician and KOL recruitment, clinical trial operations, and account-level intelligence, whereas generalist firms may lack the necessary medical and regulatory depth for these specialized studies.
Are there global healthcare research firms with local panels in Brazil?
Yes, global firms like IQVIA, Kantar, and Global Vox Populi maintain significant local presence and proprietary panels in Brazil. These firms combine global standards for data quality and compliance with in-country teams that understand the local healthcare environment and regulatory requirements.
What is the best way to recruit physicians for research in Brazil?
The best approach is to use proprietary panels recruited through professional associations, medical registries, and verified CME communities. This makes sure that the physicians are legitimate practitioners. Relying on organic or open recruitment often leads to high fraud rates and low engagement, which can jeopardize the validity of your research results.
How does ANVISA regulation impact market research in Brazil?
ANVISA regulations dictate how clinical data and pharmaceutical information must be handled. Market research providers must protect their methodology, especially regarding patient data and adverse event reporting, complies with these guidelines. Failure to follow these standards can lead to legal complications and may invalidate the research results for use in regulatory or clinical submissions.
What are the top healthcare market research agencies based in São Paulo?
These firms benefit from being at the center of Brazil's healthcare and pharmaceutical industry, allowing them to manage complex projects effectively.
How do I verify the quality of healthcare market research data in Brazil?
Quality verification involves checking for verified medical licenses, applying device and identity fingerprinting, and using trap questions. You should ask providers for their specific data cleaning procedures and request evidence of how they remove bots, speeders, and straight-liners before the data is delivered to your team.
What should I look for in a healthcare research proposal for Brazil?
A strong proposal should explicitly state the source of the sample, the verification method for professional credentials, and how they handle regulatory compliance. It should also include a realistic feasibility assessment and a clear description of the quality controls they will apply during the fieldwork phase.